| Literature DB >> 35685103 |
Ach Taïeb1,2,3, Lemdjo Gaëlle1,4, Ducloux Roxane1, Wojewoda Perrine1, Albentosa Marion1, Bougeniere Fleur1, Leriche Zoé1, Leveque Aurélie1, Dennetiere Solen1, Dutrieux Patricia1, Averous Véronique1.
Abstract
A multidisciplinary team is composed of various healthcare professionals that ensure a multifaceted approach on a group of patients. Standards for diabetes medical care note the importance of multidisciplinary diabetes care teams. We applied our model of multidisciplinary approach by structuring it in a determined five days hospitalization. The aim of this study was to determine if the interdisciplinary approach applied on a short hospitalization is of benefit in patients with poorly controlled diabetes mellitus. Sixty-seven patients were included and ensured a short hospitalization in which they received a multiple educational advice and a treatment adaptation. Sixty-one patients out of 67 (91%) were retained for evaluation with sufficient data at one year, i.e. 9% of patients with poor compliance. Evolution in glycosylated haemoglobin (HbA1c), weight and treatments was analyzed. After a 12 months follow-up, we observed significant improvement in HbA1c (-1.73%; p < 103) without weight loss (BMI=-0.42 kg/m2), p=0.28). HbA1c mean levels correlated negatively to body mass index (BMI) during the regular follow-up (r=-0.22, p=0.05). More than 90% of patients with poorly controlled diabetes mellitus responded to the multi-disciplinary approach with a decrease in HbA1c. Copyright: Ach Taïeb et al.Entities:
Keywords: Diabetes; health care education; nursing role; nutritional care; primary health care; professional education
Mesh:
Substances:
Year: 2022 PMID: 35685103 PMCID: PMC9146601 DOI: 10.11604/pamj.2022.41.192.23965
Source DB: PubMed Journal: Pan Afr Med J
Figure 1study profile and final included patients
patients´ baseline characteristics at inclusion
| Variables | Parameters | Frequency % (n) |
|---|---|---|
|
| men | 52.5% (n=32) |
| Women | 47.5 (n=29) | |
|
| ||
| < 24.9 kg/m2 | 16.4% (n=10) | |
| 25-29.9 kg/m2 | 32.8% (n=20) | |
| 30- 34.9 kg/m2 | 23% (n=14) | |
| 35-39.9 kg/m2 | 14.8% (n=9) | |
| > 40 kg/m2 | 13.1% (n=8) | |
|
| ||
| <8% | 22.9% (n=14) | |
| 8 - 9.9% | 31.1% (n=19) | |
| 10 - 11.9% | 32.7% (n=20) | |
| 12-13.9% | 11.5% (n=7) | |
| >14% | 1.6% (n=1) |
anti-diabetic protocols before and after hospitalization
| Variables | Parameters | Before Hospitalization % (n) | After treatment change % (n) |
|---|---|---|---|
|
| OAD only | 29.5% (n=18) | 8.2% (n=5) |
| OAD + GLP-1 | 4.9% (n=3) | 11.5% (n=7) | |
| Insulin only | 44.3% (n=27) | 49.2% (n=30) | |
| OAD + Insulin | 18% (n=11) | 24.6% (n=15) | |
| Insulin + GLP-1 | 1.6% (n=1) | 1.6% (n=1) | |
| OAD + Insulin + GLP1 | 1.6% (n=1) | 4.9% (n=3) | |
|
| |||
| Metformin | 34.4% (n=21) | 42.6% (n=26) | |
| Sulfonylureas | 26.3% (n=16) | 16.4% (n=10) | |
| Gliptin | 18% (n=11) | 9.8% (n=7) | |
| Glinide | 9.8% (n=7) | 3.3% (n=6) | |
|
| |||
| Basal | 14.8% (n=9) | 14.8% (n=9) | |
| Basal Plus | 1.6% (n=1) | 3.3% (n=2) | |
| Basal Bolus | 34.4% (n=21) | 48.8% (n=29) | |
| Premix Insulins | 6.6% (n=4) | 6.6% (n=4) | |
| Insulin pump | 8.1% (n=5) | 6.6% (n=4) |
OAD: oral antidiabetic drugs; GLP1-A: Glucagon-like peptide-1 analogue; (*) : glitazones and gliflozins are not available in France.
Figure 2mean HbA1c levels and evolution through one year of regular follow-up
Figure 3mean body mass index and evolution through one year of regular follow-up